Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker VVOS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 21, 2026 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Oct 19, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 15, 2026 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 15, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 15, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 1, 2026 | VVOS Vivos Therapeutics, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Sep 8, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K/A | 8-K ↗ |
| Sep 8, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K/A | 8-K ↗ |
| Sep 8, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 8, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 21, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 3, 2026 | VVOS Vivos Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 3, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 7, 2026 | VVOS Vivos Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 7, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 7, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 25, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 25, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 16, 2026 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 16, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 16, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 8, 2026 | VVOS Vivos Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 8, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 8, 2026 | VVOS Vivos Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jun 8, 2026 | VVOS Vivos Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 8, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 22, 2026 | VVOS Vivos Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Apr 15, 2026 | VVOS Vivos Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 3, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 3, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 6, 2026 | VVOS Vivos Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 20, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 20, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 16, 2026 | VVOS Vivos Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 16, 2026 | VVOS Vivos Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 16, 2026 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 17, 2025 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 5, 2025 | VVOS Vivos Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Dec 5, 2025 | VVOS Vivos Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 19, 2025 | VVOS Vivos Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2025 | VVOS Vivos Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Oct 24, 2025 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 18, 2025 | VVOS Vivos Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 16, 2026, 1:09 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances